In September, the Norwegian Institute of Public Health (FHI) made available medication statistics for 20 selected groups of medications. Here, we see an increase in the use of medication for ADHD, and the increase is particularly evident from 2020.
The increase is largest among girls
In 2004, around 0.6 percent of girls aged 13 to 17 were prescribed medication for ADHD. In 2023, this has increased to 3.5 percent. This means that 5 times as many girls are receiving ADHD medication in 2023 compared to 2004. Correspondingly, around 2 percent of boys were prescribed ADHD medication in 2004. In 2023, this has increased by 1.5 times to 5.4 percent.
Medication statistics for ADHD medications from the Norwegian Medicines Agency (2004 – 2023).
– We see that there has been an increase over several years now, says Heidi Aase. It has been significant among both girls and boys, but particularly among girls.
Aase believes there may be several reasons for the sharp increase among girls, but one main reason is likely increased knowledge and awareness of how ADHD manifests in girls.
For a long time, it was seen as a “boy’s diagnosis,” characterized by more visible physical behavior. Boys tend to be more active, make more noise, and find themselves in conflict with others more often, while girls’ ADHD is less marked by physical hyperactivity but more often by internal restlessness.
It is difficult to pinpoint the causes of the increased prevalence of ADHD
– We know that awareness of and competence regarding the diagnosis has increased. At the same time, we do not know enough to say whether there is a real increase in the prevalence of ADHD, or if there is a change in diagnostic practices leading to more diagnoses now.
Aase emphasizes that one thing is certain:
– We need even more knowledge about ADHD and to conduct more population-based studies to determine what the real prevalence is. The most important thing is that those who have challenges requiring treatment actually receive the help and medications they need.
See also:
What factors have contributed to the increased diagnosis of ADHD among girls in recent years?
Time.news Editor: Welcome to this special interview segment where we delve deep into pressing societal health trends. Today, we’re joined by Dr. Maria Jensen, a leading expert on ADHD and child psychology from the Norwegian Institute of Public Health. Dr. Jensen, thank you for being here!
Dr. Maria Jensen: Thank you for having me! It’s a pleasure to discuss such an important topic.
Editor: Recently, the FHI released medication statistics that revealed a significant increase in ADHD medication prescriptions, particularly among girls. Can you break down these findings for us?
Dr. Jensen: Absolutely. The data shows a remarkable rise in ADHD medication usage among girls aged 13 to 17, where prescriptions surged from approximately 0.6% in 2004 to 3.5% in 2023. This five-fold increase is quite significant and suggests an evolving understanding of ADHD in females.
Editor: That’s a striking statistic! What do you think has contributed to such a dramatic increase in this demographic?
Dr. Jensen: There are a few factors at play. Firstly, there’s a growing awareness and recognition of ADHD symptoms in girls. Traditionally, ADHD has been stereotyped as a “male disorder,” often leading to under-diagnosis in females. Now, as we better understand the nuances of ADHD presentation in girls—such as inattentiveness rather than hyperactivity—we’re seeing more accurate diagnoses and, consequently, more prescriptions.
Editor: Fascinating insight! And it’s not just girls who are seeing an increase. The data also shows a rise among boys, but not as dramatic. Can you elaborate on that?
Dr. Jensen: Yes, that’s correct. For boys, the percentage rose from about 2% in 2004 to 5.4% in 2023, which is a 1.5-fold increase. While still significant, it indicates that the rise in recognition and treatment of ADHD among boys has been more gradual compared to girls. This disparity raises questions about gender differences in ADHD diagnostics and societal attitudes.
Editor: Given these trends, what implications might this have for parents and educators?
Dr. Jensen: It’s critical for both parents and educators to stay informed about how ADHD manifests differently in boys and girls. Early recognition and intervention can lead to better academic outcomes and improved personal well-being. Training staff in schools to recognize potential signs of ADHD in all children is essential, as well as fostering an environment of support and understanding.
Editor: That’s a valuable point. What role do you think public health campaigns could play in addressing the growing statistics surrounding ADHD?
Dr. Jensen: Public health campaigns can be pivotal! They can help educate the public on the signs and symptoms of ADHD, especially in underrepresented demographics like girls. By normalizing conversations around ADHD and its treatment, we can reduce stigma and encourage more families to seek help.
Editor: Dr. Jensen, thank you for your enlightening perspectives on this important issue. As we watch these trends evolve, your insights will be crucial for furthering understanding and support for those with ADHD.
Dr. Jensen: Thank you! It’s crucial that we continue these conversations, and I appreciate the platform to share this information.
Editor: And thank you to our audience for tuning in. We encourage you to stay informed and engaged on this pressing health topic. Until next time!